Laurus Labs Limited (LAURUSLABS) Share Price & AI Investment Analysis

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In. Track Laurus Labs Limited's live NSE:LAURUSLABS share price ₹2,006.50 (-0.55%), market cap ₹₹1.08T, P/E 99.4. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for LAURUSLABS — real-time NSE India stock intelligence.